Metastatic Microsatellite-stable Colorectal Cancer
6 clinical trials · Condition
◉ Watch Metastatic Microsatellite-stable Colorectal Cancer
| Record | Firm | Date |
|---|---|---|
| Vorbipiprant (CR6086) / Balstilimab (AGEN2034) Combination in Stage IV Refractory pMMR - MSS CRC, and Other Metastatic GI Cancers (NCT05205330) | Rottapharm Biotech | 2021-11-23 |
| Nivolumab+Ipilimumab+RT in MSS mCRC (NCT04575922) | Massachusetts General Hospital | 2020-10-05 |
| COLUMBIA-1: Novel Oncology Therapies in Combination With Chemotherapy and Bevacizumab as First- Line Therapy in MSS-CRC (NCT04068610) | MedImmune LLC | 2019-09-13 |
Track Metastatic Microsatellite-stable Colorectal Cancer automatically
Every clearance here is in the API, with alerts when new ones post.